Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients

Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients

The use of contralateral risk reducing mastectomy (CRRM) is indicated in women affected by breast cancer, who are at high risk of developing a contralateral breast cancer, particularly women with genetic mutation of BRCA1, BRCA2 and P53. However we should consider that the genes described above acco...

Full description

Bibliographic Details
Main Authors: Falco Giuseppe, Rocco Nicola, Bordoni Daniele, Marano Luigi, Accurso Antonello, Buccelli Claudio, Di Lorenzo Pierpaolo, Capasso Emanuele, Policino Fabio, Niola Massimo, Ferrari Guglielmo
Format: Article
Language:English
Published: De Gruyter 2016-01-01
Series:Open Medicine
Subjects:
Breast Cancer
contralateral risk reducing mastectomy
Non-mutated patients
Online Access:http://www.degruyter.com/view/j/med.2016.11.issue-1/med-2016-0047/med-2016-0047.xml?format=INT

Internet

http://www.degruyter.com/view/j/med.2016.11.issue-1/med-2016-0047/med-2016-0047.xml?format=INT

Similar Items